contact | sitemap | search:     


Bezoeker
Kies een gebied:
Home > SynCo in the Press > E-Communications
Home
About Us
Brief history of SynCo Management Team Company Status
Services
Process and Analytical Development Microbial Production Mammalian Cell-based Production Aseptic Filling and Lyophilization Quality Control Quality Assurance Stability Studies Process Validation Regulatory Affairs Support Downloads
Working with SynCo
Responding to RFPs Project Management Case Studies
Filling of New Product Type at SynCo Focus on Cost of Goods During Process Development
SynCo in the Press
Press Releases
2009 Archive
SynCo Bio Partners enters the Japanese market as i... SynCo Bio Partners to Manufacture Versartis Novel ... SynCo Bio Partners Increases its capacities by Exp... SynCo Bio Partners wins Best Contract Manufacturin...
2008 Archive
SynCo Bio Partners completes manufacture and relea... OncoMed chooses SynCo Bio Partners to fill and fin...
2007 Archive
Cleveland BioLabs Completes Manufacturing Process ... SynCo Bio Partners Signs Pharmaceutical Service Ag...
2006 Archive
Cleveland Biolabs Signs Manufacturing Agreement wi...
2005 Archive
SynCo Bio Partners Develops new GMP facilities First Commercial Vaccine against Traveller's Diarr... Alliance for the Manufacture of plasmid DNA
SynCo Bio Partners and Versartis Expand Collaborat... SynCo Expands Agreement with OncoMed Pharmaceutica... SynCo Bio Partners Signs New Manufacturing Agreeme...
Articles E-Communications
Where to meet SynCo Contact Us Recruitment
Nederlands
Vacatures
Engineer Hoofdtechnician Microbiology Operator Manufacturing QA Officer
Sollicitatieprocedure Open sollicitatie Stage Contact
English
Vacancies Application procedure Open application Internship Contact us
Vacancies
E-Communications

CMO–Client Relationships that Transcend Borders and Oceans
Interview with Pierre Warffemius, SynCo's Chief Executive Officer


 

 

 

Click here to download audio file
 
2007 - 2010 All Rights Reserved, SynCo, Amsterdam